Sofosbuvir & Ledipasvir Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Sofosbuvir 400 mg & Ledipasvir 90 mg
Reference Brands: Harvoni®(EU & US)
Category:
Anti Viral
Sofosbuvir & Ledipasvir Tablets (400/90 mg) treat Hepatitis C with high cure rates. Available under brands like Harvoni®, Ledifos®, and Hepcinat-LP®, they can be bulk-sourced via PharmaB2B platforms from WHO-GMP-approved manufacturers for tenders, NGOs, and HCV treatment programs worldwide.
Sofosbuvir & Ledipasvir is available in Tablet
and strengths such as Sofosbuvir 400 mg & Ledipasvir 90 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Sofosbuvir & Ledipasvir is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Sofosbuvir & Ledipasvir can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Sofosbuvir & Ledipasvir Tablets (400 mg/90 mg) are a powerful, once-daily combination therapy for chronic Hepatitis C. Marketed under global brands like Harvoni®, Ledifos®, and Hepcinat-LP®, this fixed-dose antiviral regimen is recommended by WHO and major liver associations. It offers high cure rates with minimal side effects across genotypes 1, 4, 5, and 6. On PharmaB2B platforms, global buyers can source WHO-GMP and USFDA-approved generic alternatives from trusted Indian manufacturers. Ideal for institutional procurement, NGO supply, and public health programs, Sofosbuvir + Ledipasvir helps scale access to life-saving HCV treatment worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing